AI summary · may contain errors
The 2026 ADA/EASD consensus report updates adult type 1 diabetes management, emphasizing new technologies and revised evidence, including interventions aimed at delaying stage 3 onset.
- 1 cited this week
- Open access
Moving in Diabetes Care.
Rebuilt
AI summary · may contain errors
The 2026 ADA/EASD consensus report updates adult type 1 diabetes management, emphasizing new technologies and revised evidence, including interventions aimed at delaying stage 3 onset.
Newest first · last 60 days
AI summary · may contain errors
Smart insulin pens with an integrated bolus calculator improved HbA1c more than tracking-only connected insulin pens over 12 weeks in adults with type 1 or type 2 diabetes on MDI.
AI summary · may contain errors
Continuous glucose monitoring–derived metrics can distinguish conventionally defined prediabetes from normoglycaemia and stratify future glycaemic risk, but immediate diagnostic cut-offs are not established.
AI summary · may contain errors
In Kenyan children and young adults with type 1 diabetes, 11.1% had biochemically defined thyroid dysfunction, predominantly subclinical hypothyroidism (7.4%), with no overt hyperthyroidism detected.
AI summary · may contain errors
The “It’s All One Trial” master-protocol framework for stage 3 type 1 diabetes could cut total teplizumab development time by about 45 months.
AI summary · may contain errors
Early-stage, presymptomatic type 1 diabetes mellitus is defined by having two or more islet autoantibodies, enabling detection years before hyperglycaemia and insulin need.
AI summary · may contain errors
Oral semaglutide in high-risk type 2 diabetes reduced total first-plus-subsequent 3-point MACE versus placebo (mean ratio 0.86; 95% CI 0.76–0.97).
AI summary · may contain errors
Teplizumab’s 2026 U.S. approval for children and adolescents aged 8–17 with new-onset stage 3 type 1 diabetes reshapes the first weeks after diagnosis.
AI summary · may contain errors
Hypoglycemic events in adults with type 1 diabetes occurring within 0–1 h before smartphone cognitive testing are linked to slower reaction time and poorer DSM and GCPT performance.
AI summary · may contain errors
REDDIE shows that, when real-world data are carefully aligned with study design and analysis, observational diabetes studies can replicate major randomized trial findings and extend them to broader populations.
AI summary · may contain errors
In people with recent-onset type 2 diabetes, higher long-term PM2.5 exposure is linked to higher HbA1c (exp[β]=1.04, 95% CI 1.01–1.06) and worse glucose homeostasis biomarkers.
AI summary · may contain errors
An early-stage synthetic immunological niche (IN) gene signature in non-obese diabetic (NOD) mice stratifies progressors from non-progressors by 6 weeks and is conserved in human T1D tissues.
AI summary · may contain errors
Childhood type 1 diabetes incidence in Finland fell after the COVID-19 lockdown, with an incidence rate ratio of 0.85 versus the lockdown period.
AI summary · may contain errors
Lower fecal elastase-1 during the first 6 months of life predicts later multiple islet autoantibodies or type 1 diabetes in ENDIA children, with β-coefficients down to -0.61 at birth.
AI summary · may contain errors
GLP-1 receptor agonist initiation in adults with schizophrenia and type 2 diabetes in the USA is linked to lower psychiatric hospitalisation risk (weighted HR 0·76).
AI summary · may contain errors
Liver-kidney crosstalk coordinated by glucagon links gluconeogenesis, nitrogen handling, and acid-base control, with urea and ammonium fluxes shifting in fasting and metabolic acidosis.
AI summary · may contain errors
Ketoacidosis occurred at an incidence of 2·43 per 1000 person-years during SGLT2 inhibitor treatment episodes in adults with type 2 diabetes across three Scandinavian countries.
AI summary · may contain errors
Each 1-year later diagnosis of type 1 diabetes in adults is linked to lower all-cause mortality risk (HR 0.98, 95% CI 0.98–0.99) in Sweden.
AI summary · may contain errors
In OUTSTAND-2, oral safiglipron in adults with type 2 diabetes is non-inferior to dapagliflozin for HbA1c change at week 32 for 30 mg, 60 mg, and 90 mg.
AI summary · may contain errors
Higher last bolus and basal insulin doses in adults with type 1 diabetes are linked to increased cardiac sympathetic predominance, measured by LF/HF, during early and late sleep phases.
AI summary · may contain errors
Higher CGM time below range—especially TBR <70 mg/dL—and greater glucose variability are linked to increased severe hypoglycemia risk in 1,550 people with type 1 diabetes.
Journals this month
Topics moving, week to 17 Nov 2026
By field